1
项与 Monoclonal antibody (Mab) sB24M(SWISS BIOPHARMA) 相关的临床试验Phase 0/1 Topical Application of the Monoclonal Antibody (Mab) sB24M in Patients With Severe Pyoderma
Phase 0/1 local application of the monoclonal antibody (Mab) sB24M in patients with purulent pyoderma (chronic ulcerative pyoderma) by injection into the affected areas.
Monoclonal antibody (Mab) sB24 negatively regulates immune-inflammatory processes through CD47 / TNF-α Axis promotes epithelialization of damaged tissue.
100 项与 Monoclonal antibody (Mab) sB24M(SWISS BIOPHARMA) 相关的临床结果
100 项与 Monoclonal antibody (Mab) sB24M(SWISS BIOPHARMA) 相关的转化医学
100 项与 Monoclonal antibody (Mab) sB24M(SWISS BIOPHARMA) 相关的专利(医药)
100 项与 Monoclonal antibody (Mab) sB24M(SWISS BIOPHARMA) 相关的药物交易